Literature DB >> 18571909

High phosphate content beverages in dialysis patients: relevance for hyperphosphatemia and cardiovascular risk.

Vincenzo Savica, Lorenzo A Calò, Paolo Monardo, Renato Caldarera, Adelaide Cavaleri, Domenico Santoro, Ugo Muraca, Agostino Mallamace, Guido Bellinghieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18571909     DOI： 10.1016/j.numecd.2008.03.003

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN： 0939-4753            Impact factor:   4.222


× No keyword cloud information.
  2 in total

1.  Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial.

Authors:  Inger H Bleskestad; Harald Bergrem; Anders Hartmann; Kristin Godang; Lasse G Gøransson
Journal:  BMC Nephrol       Date:  2012-06-28       Impact factor: 2.388

2.  Restriction of Dietary Phosphate Ameliorates Skeletal Abnormalities in a Mouse Model for Craniometaphyseal Dysplasia.

Authors:  Yasuyuki Fujii; Eszter Kozak; Eliane Dutra; Andras Varadi; Ernst J Reichenberger; I-Ping Chen
Journal:  J Bone Miner Res       Date:  2020-07-12       Impact factor: 6.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.